CClinicalTrials.gg
Status unknownNCT01156285Updated Nov 29, 2011

Acute Anterior Uveitis: Psychic Burden and Pain

An observational study in Anterior Uveitis, sponsored by Hospital Hietzing. Status unknown at 2 sites in Austria. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2011-11-29.

Sponsored by Hospital Hietzing · Observational

The sponsor has not verified this record recently (last verified Nov 2011), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
35
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Acute anterior uveitis (AU) is a common reason for attendance at ophthalmic outpatient clinics. The painfulness and the fear of a transient or even persistent loss of vision may markedly reduce the individual's subjective well-being and pose a psychological burden.

This study will test the hypothesis that during an attack of AU the patient experiences a marked reduction in psychological and physical well-being.

Prospective, hospital-based epidemiologic study using a patient questionnaire with standardized psychological tests and a pain scale.

02

Conditions studied

  • Anterior Uveitis
03

In context

Uveitis

335 studies on the registry are indexed under Uveitis; 37 are open to participants now.

This study's planned enrollment of 35 is below the median of 100 across 107 observational studies indexed under Uveitis.

Browse Uveitis studies →

Lead sponsor

Hospital Hietzing is the lead sponsor of 15 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients with acute attack of anterior uveitis

Inclusion criteria

  • Acute attack of anterior uveitis

Exclusion criteria

Exclusion Criteria:

  • Other forms of uveitis
  • Chronic anterior uveitis
  • Therapy started
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
35 participants (estimated)

Groups and cohorts

  • AAU

    patient with acute attack of anterior uveitis

    Other: Filling in a patient questionnaire

Interventions

  • OtherFilling in a patient questionnaire

    Filling in a patient questionnaire

06

Study locations

1 of 2 sites recruiting
  • Department of Ophthalmology, Medical University Graz
    Graz, Styria, Austria
    • Andreas Wedrich, MD, Prof. · Contact · 43-316-385
    • Andreas Wedrich, MD, Prof · Principal investigator
    • Julia Wagner, MD · Sub investigator
    Not yet recruiting
  • Department of Ophthalmology, Hietzing Hospital
    Vienna, 1130, Austria
    • Saskia M Maca, MD · Principal investigator
    Recruiting
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 29, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01156285
Lead sponsor
Hospital Hietzing
Collaborators
Medical University of Graz
Responsible party
Saskia M Maca (MD, Hospital Hietzing) — Principal investigator
First posted
Jul 2, 2010
Start date
May 2010
Completion
Jun 2012 (estimated)
Last update
Nov 29, 2011

Study contacts

Saskia M Maca, MD
Contact
Saskia.Maca@wienkav.at
+43-1-80110 ext. 2266
Saskia M Maca, MD
study director · Hospital Hietzing

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion